Variable antipyretic effect of SC-58236, a selective cyclooxygenase (COX)-2 inhibitor, in rats.
Akarsu
Eyup S
ES
Ankara University, Faculty of Medicine, Department of Pharmacology and Clinical Pharmacology, Turkey.
Mamuk
Soner
S
Arat
Sibel
S
D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D005334:Fever / Q000188:drug therapy / Q000201:enzymology; D007279:Injections, Subcutaneous; D007527:Isoenzymes / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011720:Pyrazoles; D051381:Rats; D017208:Rats, Wistar; D013449:Sulfonamides; D013997:Time Factors; D000096926:Benzenesulfonamides
D018712:Analgesics, Non-Narcotic; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D011451:Prostaglandin-Endoperoxide Synthases; D011720:Pyrazoles; D013449:Sulfonamides; C119130:4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide; D000096926:Benzenesulfonamides